The significant association between PREX1 and MMP10 expression in luminal tumors, together with the poor prognosis found in luminal breast cancer patients with high PREX1 and MMP10 expression, suggest a causal relationship with disease progression that deserves to be fully explored. This evidence concerns the gene MMP10 and breast cancer.